Cargando…

Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression

Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration due to dystrophin gene mutations. Patients with DMD initially experience muscle weakness in their limbs during adolescence. With age, patients develop fatal respiratory and cardiac dysfunctions....

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Min Ho, Yoo, Jimeen, Oh, Jae Gyun, Kook, Hyun, Park, Woo Jin, Jeong, Dongtak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088811/
https://www.ncbi.nlm.nih.gov/pubmed/35557546
http://dx.doi.org/10.3389/fcvm.2022.763544
_version_ 1784704389340987392
author Song, Min Ho
Yoo, Jimeen
Oh, Jae Gyun
Kook, Hyun
Park, Woo Jin
Jeong, Dongtak
author_facet Song, Min Ho
Yoo, Jimeen
Oh, Jae Gyun
Kook, Hyun
Park, Woo Jin
Jeong, Dongtak
author_sort Song, Min Ho
collection PubMed
description Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration due to dystrophin gene mutations. Patients with DMD initially experience muscle weakness in their limbs during adolescence. With age, patients develop fatal respiratory and cardiac dysfunctions. During the later stages of the disease, severe cardiac fibrosis occurs, compromising cardiac function. Previously, our research showed that the matricellular protein CCN5 has antifibrotic properties. Therefore, we hypothesized that CCN5 gene transfer would ameliorate cardiac fibrosis and thus improve cardiac function in DMD-induced cardiomyopathy. We utilized mdx/utrn (±) haploinsufficient mice that recapitulated the DMD-disease phenotypes and used an adeno-associated virus serotype-9 viral vector for CCN5 gene transfer. We evaluated the onset of cardiac dysfunction using echocardiography and determined the experimental starting point in 13-month-old mice. Two months after CCN5 gene transfer, cardiac function was significantly enhanced, and cardiac fibrosis was ameliorated. Additionally, running performance was improved in CCN5 gene-transfected mice. Furthermore, in silico gene profiling analysis identified utrophin as a novel transcriptional target of CCN5. This was supplemented by a utrophin promoter assay and RNA-seq analysis, which confirmed that CCN5 was directly associated with utrophin expression. Our results showed that CCN5 may be a promising therapeutic molecule for DMD-induced cardiac and skeletal dysfunction.
format Online
Article
Text
id pubmed-9088811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90888112022-05-11 Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression Song, Min Ho Yoo, Jimeen Oh, Jae Gyun Kook, Hyun Park, Woo Jin Jeong, Dongtak Front Cardiovasc Med Cardiovascular Medicine Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration due to dystrophin gene mutations. Patients with DMD initially experience muscle weakness in their limbs during adolescence. With age, patients develop fatal respiratory and cardiac dysfunctions. During the later stages of the disease, severe cardiac fibrosis occurs, compromising cardiac function. Previously, our research showed that the matricellular protein CCN5 has antifibrotic properties. Therefore, we hypothesized that CCN5 gene transfer would ameliorate cardiac fibrosis and thus improve cardiac function in DMD-induced cardiomyopathy. We utilized mdx/utrn (±) haploinsufficient mice that recapitulated the DMD-disease phenotypes and used an adeno-associated virus serotype-9 viral vector for CCN5 gene transfer. We evaluated the onset of cardiac dysfunction using echocardiography and determined the experimental starting point in 13-month-old mice. Two months after CCN5 gene transfer, cardiac function was significantly enhanced, and cardiac fibrosis was ameliorated. Additionally, running performance was improved in CCN5 gene-transfected mice. Furthermore, in silico gene profiling analysis identified utrophin as a novel transcriptional target of CCN5. This was supplemented by a utrophin promoter assay and RNA-seq analysis, which confirmed that CCN5 was directly associated with utrophin expression. Our results showed that CCN5 may be a promising therapeutic molecule for DMD-induced cardiac and skeletal dysfunction. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9088811/ /pubmed/35557546 http://dx.doi.org/10.3389/fcvm.2022.763544 Text en Copyright © 2022 Song, Yoo, Oh, Kook, Park and Jeong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Song, Min Ho
Yoo, Jimeen
Oh, Jae Gyun
Kook, Hyun
Park, Woo Jin
Jeong, Dongtak
Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title_full Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title_fullStr Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title_full_unstemmed Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title_short Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression
title_sort matricellular protein ccn5 gene transfer ameliorates cardiac and skeletal dysfunction in mdx/utrn (±) haploinsufficient mice by reducing fibrosis and upregulating utrophin expression
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088811/
https://www.ncbi.nlm.nih.gov/pubmed/35557546
http://dx.doi.org/10.3389/fcvm.2022.763544
work_keys_str_mv AT songminho matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression
AT yoojimeen matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression
AT ohjaegyun matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression
AT kookhyun matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression
AT parkwoojin matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression
AT jeongdongtak matricellularproteinccn5genetransferamelioratescardiacandskeletaldysfunctioninmdxutrnhaploinsufficientmicebyreducingfibrosisandupregulatingutrophinexpression